Aug 11 (Reuters) - GE:
* FDA advisory committee recommends GE healthcare's Datscan(TM) (ioflupane i
123 injection)
* Healthcare says panel determined datscan has a favorable risk to benefit
profile, voting 11 to two
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780)) (For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* FDA advisory committee recommends GE healthcare's Datscan(TM) (ioflupane i
123 injection)
* Healthcare says panel determined datscan has a favorable risk to benefit
profile, voting 11 to two
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780)) (For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.